Jun, 03, 2009

WASHINGTON (Reuters) - A gene that is highly active in up to 20 percent of breast cancer cases might be blocked by a generically available blood pressure drug, U.S. researchers reported on Tuesday.


(C) reuters

• read the news on the original publisher's site